Background & Sources: Follow-up care timeline for Benzene-related Acute Myeloid Leukemia

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Primary topic reference

Follow-up care timeline for Benzene-related Acute Myeloid Leukemia — Background & Analysis — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.